We would love to hear your thoughts about our site and services, please take our survey here.
The next two weeks we are on the steep part of the infection rate curve. I doubt this guy was working as a hermit so it will affect others, and replacement of lost crew may be hard at present. The timing of this infection is bad news. I have now swapped my cash out of Hur and into jog, which is where Hur was 12 months ago. The depression in jog price due to low oil price and impatience waiting for first oil is overdone, having said that if the firm is badly affected by covid I would sell that one too. I didn't spend the lot and am looking at Ukog with a view to hope of an imminent announcement about pedl143 ... (They need a landowner to lease them some land).. haven't bought in yet though
https://ukinvestormagazine.co.uk/the-greatland-gold-share-price-offers-a-buying-opportunity/
None of my buys, or sells, has ever shown up. I use a UK broker. Won't say which for security reasons but nothing small or off. A friend reports same, different broker. I therefore find myself wondering if liquidity isn't vastly more than what shows here. You get these ticks up and down in price and no trades showing at that time at all, only 2 all of today showing. Could be soaked up by MMs of course. But mine should show. When it was RNS'd Friday that two investors bought 20% of eden the trades didn't show. Just far smaller ones. I'd prefer that the trades all show.
Drat. That was almost their only income and now Merck will pay a lot less. Nano will have to settle for whatever is offered, unless it has invisible leverage. We needed that like a hole in the head. Blow after blow after blow.
https://www.telegraph.co.uk/news/2020/03/25/coronavirus-antibody-home-testing-kits-will-available-within/ wow, 3 million antibody tests available via Boots next week. I really want to know who is making this test as sales will vastly exceed that. I am not sure that retail buyers will understand the difference between this and an antigen test like NYCT's and so many other firms. I would want to buy the antibody test. If I get a massive temperature and cough I know what it is already. But, if I had it mildly, unknown, and am now shown to be immune then I can go volunteer as a nurse and so can every other immune person, probably all 200,000 of them. It's this test that is the breakthrough we need.
I'd rather nurses at GPs at least did it for a good sample of us (at least 1,000 nationally) at about the same date each week and logged the results for epidemiological modelling (spread) purposes. Ignore all other results. I don't trust the public to do it right or send in the results to their doc.
It depends on retail outlets. I wouldn't invest in anything retail-based at the moment.
https://mol.im/a/8132593 test kit launched by Texan firm
https://mol.im/a/8143443 a Carolina firm is making a covid test that needs no lab equipment and gives a result in minutes, like a strip of litmus. The sample doesn't therefore need to be handled multiple times or transported to some expensive weird machine, not are skills needed to do the test which the suspect can do himself at home. That sounds just what the doctor ordered.
https://mol.im/a/8141997 aha, the British government is taking receipt of millions of the antibody tests within 2 or 3 weeks. Sounds like mologic but firm not named.
It's not showing but mid-day today I bought £5499 at 5.995p, just below the 6p mechanism on Friday ... I think Eden has everything going for it this year. People still need food on their tables and still want fewer of the bad chemicals.
I suppose you are right. Other countries are also developing antibody tests I see, even though UK test is really close to deployment with government support .. team at the Icahn School of Medicine in New York City just developed the very test. Their test, described in a preprint paper released today, looks for tell-tale antibodies to the coronavirus in people’s blood, and is similar to the most widely used type of test for HIVmodelers are missing an accurate denominator of the death-rate calculation.
That’s a huge problem for setting policyIf someone has been exposed, their blood should be full of antibodies against the virus. It’s the presence, or absence, of such antibodies to the virus that the new test measures.
The Icahn team, led by virologist Florian Krammer, says the new test could help locate survivors, who could then donate their antibody-rich blood to people in ICUs to help boost their immunity.
What’s more, doctors, nurses, and health-care workers could learn if they’ve already been exposed. Those who have, assuming they are now immune, Krammer suggests, could safely rush to the front lines and perform the riskiest tasks—like intubating a person with the virus, without worrying about getting infected or bringing the disease home to their families. The test can pick up the body’s response to infection from three days post onset of infection.
Our test is for viral DNA. Detects a live ongoing infection. The test referred doesn't exist yet, and detects antibodies, hence developed immunity. I dare say some antibodies would arise very fast in the infection. Antibody test great as if you had it so mildly you didn't know, or weren't sure what it was , this can tell you if you are innoculated or.not.. also it can tell government how many are immune if a number are tested at a point in time, and that will aid in spread modelling. So far government can only guess how many have had it mildly or even asymptomatically. The CMO and .sounded optimistic about this antibody test. Whilst this is bad for our stock, we should welcome it as citizens and wish it well. Because we are not ghouls.
The £3.7m NHS order should have been worth more on the share price. Look I understand that other tests are coming along including possibly an almost instant one, BUT sales to 60 countries (some of batches of research samples but I imagine some of more) and this big NHS order... They can make hay for between 1.5 to 6 weeks before anything better or cheaper comes in with luck.. oh well. See how it does tomorrow.
Rapid Covid-19 self-testing kit set for UK release
A British company has developed a rapid diagnostic self-testing kit for Covid-19 – Channel 4 News can exclusively reveal.
A British company has developed a rapid diagnostic self-testing kit for Covid-19 – Channel 4 News can exclusively reveal.
The 10-minute testing kit for Covid-19 will be distributed around the UK from next week – in what is believed to be the first rapid test available in this country.
The kits will be distributed for use by health care professionals next week – in order that pharmacists are able to test their staff.
Channel 4 News was given exclusive access as the company prepared the highly sought-after kits – and have been told that they hope to make the self-testing kits available to the public within three weeks!!!
The company says results can be obtained in around 10 minutes. Currently NHS testing takes four hours. The new kit works in the same way blood sugar is tested by using a pin prick on patients’ thumbs.
Given the obvious demand, the company have requested we do not detail their name or the location of where they are based – for the time being. (Wow)
https://www.evaluate.com/vantage/articles/news/policy-and-regulation/few-groups-have-developed-covid-19-diagnostics-will
- published 10th March : points out that Genetic tests are reasonably easy to create and deliver, and says :
"The Covid-19 outbreak means medics are now turning to Western diagnostics companies for genetic tests for the virus. Five of the top 10 IVD developers have responded to the call, alongside smaller groups and independent medical centres in Europe and the US. Genetic tests are reasonably easy to create and deliver. The virus’s genome was sequenced and published early on in the outbreak, and because of coronaviruses’ propensity to mutate it has been repeatedly sequenced since.
Roche have led the charge. Danaher and Thermo Fisher have also both made tests available, and France's Biomérieux has two on the way.
Three tests have obtained European CE mark. Most recent is the Viasure Sars-CoV-2 real time PCR detection kit, developed under a partnership between Becton Dickinson and the much smaller group Certest Biotec. The micro caps Novacyt and Co-Diagnostics also have CE-marked tests.
the companies named here represent a tiny fraction of the number actually working on Covid-19 diagnostics.
In a briefing on March 7, the FDA Commissioner Stephen Hahn said that the agency had received more than 100 requests for an EUA template, adding that 36 companies had sought the FDA’s assistance with development and validation of tests they plan to bring through the EUA process. Most of these companies will ALREADY be selling their tests in the US, but it is only when the EUAs are granted that it will become clear who they are.
Top 10 in vitro diagnostics companies' work on Covid-19
Annual sales ($bn)
Company 2019 2024 CAGR Covid-19 diagnostic?
Roche 11.1 14.2 +5% Yes, test launched
Abbott Laboratories 7.7 10.1 +6% No, but has donated testing instruments to China
Danaher 6.6 8.2 +5% Yes, test launched
Siemens Healthineers 4.6 5.6 +4% No, though has tests for other coronaviruses
Thermo Fisher Scientific 3.4 4.0* +3% Yes, test launched
Becton Dickinson 3.1 3.9 +5% Yes, test CE marked
Sysmex 2.7 3.7 +6% No, mainly cancer-focused
Exact Sciences 0.9 3.5 +32% No, cancer-focused
Biomérieux 2.4 3.3 +6% Yes, two tests in development, launch of first imminent
Ortho-Clinical Diagnostics 1.9 2.1 +2% No, though has tests for other viruses including HIV
Rest of market 15.0 22.2 +8% "
https://www.bloomberg.com/news/articles/2020-03-13/roche-gets-clearance-for-coronavirus-test-that-s-10-times-faster
U.S. health regulators have approved a new coronavirus test that will speed up by tenfold the ability to test patients, helping solve a significant obstacle to American efforts to contain the virus.
The Food and Drug Administration granted “emergency use authorization” to the test, which runs on Roche Holding AG’s cobas 6800/8800 systems. The 8800 system is capable of testing 4,128 patients a day, and the 6800 version can test as many as 1,440. The tool also is available in Europe and countries that accept its CE marking for medical devices.
This is the third test -- and first commercially available one -- granted emergency approval by the FDA. The agency in February cleared diagnostic tools brought forth by the CDC and the New York State Department of Public Health.
The cobas 6800/8800 instruments provide test results within four hours. Roche can provide millions of tests every month for the systems and is “going to the limits of its production capacity,” the company said. Roche declined to comment on pricing for the tests.
They weren't specific. That is definitely in that space. So if that is the only contender, which would be surprising as this is obviously the ultimate test (cost £1 each to make, hopefully sold for slightly more), then that could be it. Interesting to see that this is getting some of Boris' extra £46m, thanks, my research had omitted this. There doesn't appear to be a route to invest in it. At last I see people in London wearing masks in non trivial numbers, and I have actually seen men washing their hands and people using communal alcohol gel in the office repeatedly. If enough people develop these new habits and keep them up, the peak may not come for many months, maybe not even year end. Once we have seen a few dozen deaths in UK I believe these behaviours will become the norm. Roll on school Easter break